Ainos(US:AIMD)2025-11-13 21:15Financial Performance - Ainos reported revenues of $2,167 for Q3 2025, compared to $0 in Q3 2024, and $113,037 for the nine months ended September 30, 2025, up from $20,729 in the same period last year[19]. - Total operating expenses decreased by 8% year over year to $2,785,883 in Q3 2025, driven by a 22% reduction in selling, general, and administrative expenses[5]. - The company incurred a net loss of $2,931,702 for Q3 2025, compared to a net loss of $3,699,317 in Q3 2024, and a total net loss of $10,302,714 for the nine months ended September 30, 2025, compared to $10,209,149 in the same period last year[19]. Intellectual Property and Innovation - Ainos has secured seven new patents, bringing its total to 123 active patents across key technologies, reinforcing its intellectual property leadership[8]. - The company launched its first commercial portable, cloud-connected AI Nose module designed for industrial and healthcare use on August 14, 2025[11]. Market and Strategic Partnerships - Ainos has expanded its partner ecosystem to six strategic partners in the semiconductor and industrial edge AI sectors, enhancing its market position[4]. - Ainos announced a strategic partnership with NEXCOM International to integrate AI Nose technology into industrial edge computing platforms, enhancing real-time environmental sensing[7]. - The global electronic-nose market is projected to grow from approximately $45 billion in 2025 to over $130 billion by 2034, representing a 12.7% compound annual growth rate[4]. Business Model and Classification - The company reclassified under the Global Industry Classification Standard to Technology Hardware, Storage & Peripherals, reflecting its transition to digital olfaction[7]. - Ainos aims to turn years of research into recurring, data-driven value through its SmellTech-as-a-Service model, enhancing safety and efficiency across various applications[4].